전체메뉴 열기

Research and Development

EASY BIO has continued its growth into a global company with the world's leading technological expertise and competitiveness.


Bio Resource Institute

Bio Resource Institute conducts research for highly value-added products using mainly fermentation technology and microbiology. Bio Resource Institute holds numerous patents due to their outstanding research. In addition, it works on joint projects with many universities and institutes in Korea, USA and other countries.

Livestock Science R&D Center

The Livestock science R&D Center brings together the top experts of every livestock breed of livestock and feed formulation experts to manage the feed research and development areas in formulation, quality control, and overall development processes of the EASY BIO group. Through continuous research in our own farms as well as cooperation with external institutions and universities, we have achieved annual feed grade improvement and cost reduction. We are also currently evaluating the applications of the additives created by EASY BIO.


Optipharm, one of our subsidiaries, provides veterinary solutions and diagnosis of animal diseases as well as research in the diverse industry fields. Optipharm produces specific pathogenic-free pigs for medical purposes and develops recombinant proteins through animal bioreactors; Development of GMO chickens, GFP miniature pigs for organ implementation is another continuously research area at Optipharm. Optipharm ranked first with the largest market share in veterinary diagnosis sector and is increasing its scope of research to a more diverse fields of study.

Central Analysis Laboratory

The Central Analysis Laboratory is our strong analytical center of NIR, nutrients and harmful ingredients, microorganisms, and water quality for all subsidiary companies.
The Central Analysis Laboratory has been officially recognized for its quality systems and testing capabilities by obtaining accredited certification KOLAS, whose test results internationally certify the reliability of analytical institutions. In addition, the laboratory has the most advanced analytical equipment and top-level professionals who are in charge of analyzing feed and additives not only just within EASY BIO, but in the entire livestock industry in Korea.

Enzyme research center

GNC Bioferm was established in Saskatchewan, Canada in 1985 as a subsidiary company of EASY BIO Inc. and produces Non-GMO fungal enzymes for various types of animal diets. Its enzyme was the first to be registered in the EU and every enzyme produced afterwards has been officially registered as well. In addition, GNC Bioferm has received FeedAssureTM HACCP and GMP certification.

Biochemistry research center

Pathway Intermediates International was established in 2011 as a joint venture with EASY BIO and Pathway Intermediates UK in Cheonan, Korea. It has received ISO 22000, and FAMI-QS certification.
Since it has unique cutting-edge technology to provide solutions from natural lipid based molecules, Pathway Intermediates in UK received the prestigious Queens Award for enterprise in 2012 which demonstrates outstanding achievement in international trade, innovation, and sustainable development.

We also collaborate with many universities and institutes in
America, Thailand, Iran, China, Philippines, ETC.



Thank you for visiting EASY BIO's website. The contents of the site can be used for private purposes, and the 'link' and 'data' can be directly stored in PCs. However, the site is bound under certain legal restrictions and prohibitions. The restrictions and prohibitions include the following recognitions:

1. The website is an exclusive information property of EASY BIO.
Properties related to the EASY BIO website (www.easybio.co.kr) include copyrights, trademarks, technology information, pictures, images, sound bites, link, and source codes (mentioned hereafter as 'website service'), and EASY BIO possesses exclusive rights to the website service. All information is provided for the benefit and convenience of EASY BIO's customers.
However, it has to be clarified that EASY BIO is not granting the commercial using rights to the customers. Customers cannot use the website service for any purposes other than for private use.

2. EASY BIO will not be liable for any direct, indirect, incidental, special, or extended damages caused by the website service.
EASY BIO does not deem credible all materials contained in its website. Therefore, unless a special notice is given, EASY BIO's website service should not be used as supplementary information in the decision making process. Apart from the information and service it directly provides in the site, EASY BIO does not guarantee the accuracy, perfection or reliability of additional materials contained in its website. Therefore, we strongly discourage our customers from relying exclusively on information we do not guarantee.
We especially ask you to refrain from using the website for unwarranted sales, trade, and purchase transactions related to the benefits of corporations or individuals. EASY BIO will not be liable for any direct, indirect, incidental, special, or extended damages that results from the use of the information and materials contained in the website.

3. EASY BIO's website service should not be used as materials for securities transactions.
The information and materials contained in the website are not suitable to satisfy the demands and requirements of securities institutions. Therefore, the materials should not be used to make investment decisions. EASY BIO does not guarantee the reliability and credibility of materials in its website as sources for commercial and financial information.

4. The links in EASY BIO's website have no direct connection with EASY BIO
EASY BIO is providing various links in its website that are based on the individual needs of its users. Even though the links are provided for the information gathering and convenience of the users, EASY BIO is not legally responsible for any of the link sites and does not guarantee their credibility. The use of the sites is up to the discretion of each individual.